nodes	percent_of_prediction	percent_of_DWPC	metapath
Zoledronate—ABCC1—Dactinomycin—peripheral nervous system neoplasm	0.191	0.304	CbGbCtD
Zoledronate—ABCC1—Epirubicin—peripheral nervous system neoplasm	0.138	0.22	CbGbCtD
Zoledronate—ABCC1—Vincristine—peripheral nervous system neoplasm	0.117	0.187	CbGbCtD
Zoledronate—ABCC1—Etoposide—peripheral nervous system neoplasm	0.108	0.172	CbGbCtD
Zoledronate—ABCC1—Doxorubicin—peripheral nervous system neoplasm	0.0734	0.117	CbGbCtD
Zoledronate—GGPS1—trigeminal ganglion—peripheral nervous system neoplasm	0.000526	0.173	CbGeAlD
Zoledronate—GGPS1—parotid gland—peripheral nervous system neoplasm	0.000496	0.163	CbGeAlD
Zoledronate—GGPS1—brainstem—peripheral nervous system neoplasm	0.000465	0.153	CbGeAlD
Zoledronate—FDPS—trigeminal ganglion—peripheral nervous system neoplasm	0.000242	0.0799	CbGeAlD
Zoledronate—GGPS1—cerebellum—peripheral nervous system neoplasm	0.000229	0.0756	CbGeAlD
Zoledronate—FDPS—parotid gland—peripheral nervous system neoplasm	0.000229	0.0753	CbGeAlD
Zoledronate—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00017	0.000459	CcSEcCtD
Zoledronate—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000459	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000169	0.000458	CcSEcCtD
Zoledronate—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000168	0.000455	CcSEcCtD
Zoledronate—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000168	0.000454	CcSEcCtD
Zoledronate—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000454	CcSEcCtD
Zoledronate—Pain—Cisplatin—peripheral nervous system neoplasm	0.000168	0.000454	CcSEcCtD
Zoledronate—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000453	CcSEcCtD
Zoledronate—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000448	CcSEcCtD
Zoledronate—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000165	0.000447	CcSEcCtD
Zoledronate—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000447	CcSEcCtD
Zoledronate—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000165	0.000446	CcSEcCtD
Zoledronate—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000444	CcSEcCtD
Zoledronate—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000444	CcSEcCtD
Zoledronate—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000444	CcSEcCtD
Zoledronate—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000443	CcSEcCtD
Zoledronate—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000163	0.000442	CcSEcCtD
Zoledronate—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000163	0.000441	CcSEcCtD
Zoledronate—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000162	0.000438	CcSEcCtD
Zoledronate—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000161	0.000437	CcSEcCtD
Zoledronate—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000436	CcSEcCtD
Zoledronate—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000434	CcSEcCtD
Zoledronate—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00016	0.000434	CcSEcCtD
Zoledronate—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00016	0.000432	CcSEcCtD
Zoledronate—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000159	0.000431	CcSEcCtD
Zoledronate—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000427	CcSEcCtD
Zoledronate—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000427	CcSEcCtD
Zoledronate—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000158	0.000427	CcSEcCtD
Zoledronate—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000158	0.000426	CcSEcCtD
Zoledronate—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000157	0.000424	CcSEcCtD
Zoledronate—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000156	0.000423	CcSEcCtD
Zoledronate—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000421	CcSEcCtD
Zoledronate—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000155	0.00042	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000155	0.00042	CcSEcCtD
Zoledronate—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000155	0.00042	CcSEcCtD
Zoledronate—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000155	0.000419	CcSEcCtD
Zoledronate—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000417	CcSEcCtD
Zoledronate—Constipation—Etoposide—peripheral nervous system neoplasm	0.000154	0.000416	CcSEcCtD
Zoledronate—Pain—Etoposide—peripheral nervous system neoplasm	0.000154	0.000416	CcSEcCtD
Zoledronate—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000416	CcSEcCtD
Zoledronate—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000416	CcSEcCtD
Zoledronate—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000415	CcSEcCtD
Zoledronate—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000412	CcSEcCtD
Zoledronate—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000152	0.000412	CcSEcCtD
Zoledronate—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000152	0.000411	CcSEcCtD
Zoledronate—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.00041	CcSEcCtD
Zoledronate—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000408	CcSEcCtD
Zoledronate—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000404	CcSEcCtD
Zoledronate—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000401	CcSEcCtD
Zoledronate—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000148	0.000401	CcSEcCtD
Zoledronate—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000147	0.000399	CcSEcCtD
Zoledronate—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000399	CcSEcCtD
Zoledronate—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000147	0.000398	CcSEcCtD
Zoledronate—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000147	0.000397	CcSEcCtD
Zoledronate—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000146	0.000396	CcSEcCtD
Zoledronate—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000396	CcSEcCtD
Zoledronate—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000396	CcSEcCtD
Zoledronate—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000145	0.000393	CcSEcCtD
Zoledronate—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000145	0.000393	CcSEcCtD
Zoledronate—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000145	0.000391	CcSEcCtD
Zoledronate—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000391	CcSEcCtD
Zoledronate—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000144	0.00039	CcSEcCtD
Zoledronate—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000389	CcSEcCtD
Zoledronate—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000143	0.000386	CcSEcCtD
Zoledronate—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000386	CcSEcCtD
Zoledronate—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000142	0.000384	CcSEcCtD
Zoledronate—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000142	0.000384	CcSEcCtD
Zoledronate—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000384	CcSEcCtD
Zoledronate—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000384	CcSEcCtD
Zoledronate—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000382	CcSEcCtD
Zoledronate—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000141	0.000382	CcSEcCtD
Zoledronate—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000141	0.000381	CcSEcCtD
Zoledronate—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000379	CcSEcCtD
Zoledronate—Rash—Vincristine—peripheral nervous system neoplasm	0.00014	0.000379	CcSEcCtD
Zoledronate—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00014	0.000378	CcSEcCtD
Zoledronate—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000378	CcSEcCtD
Zoledronate—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000377	CcSEcCtD
Zoledronate—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000377	CcSEcCtD
Zoledronate—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000376	CcSEcCtD
Zoledronate—Headache—Vincristine—peripheral nervous system neoplasm	0.000139	0.000376	CcSEcCtD
Zoledronate—CA14—cerebellum—peripheral nervous system neoplasm	0.000137	0.0452	CbGeAlD
Zoledronate—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000137	0.00037	CcSEcCtD
Zoledronate—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000369	CcSEcCtD
Zoledronate—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000134	0.000363	CcSEcCtD
Zoledronate—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000361	CcSEcCtD
Zoledronate—ABCC1—parotid gland—peripheral nervous system neoplasm	0.000133	0.0437	CbGeAlD
Zoledronate—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000359	CcSEcCtD
Zoledronate—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000132	0.000358	CcSEcCtD
Zoledronate—Nausea—Vincristine—peripheral nervous system neoplasm	0.000132	0.000357	CcSEcCtD
Zoledronate—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000356	CcSEcCtD
Zoledronate—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000356	CcSEcCtD
Zoledronate—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000353	CcSEcCtD
Zoledronate—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000351	CcSEcCtD
Zoledronate—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.00035	CcSEcCtD
Zoledronate—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000129	0.000349	CcSEcCtD
Zoledronate—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000349	CcSEcCtD
Zoledronate—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000348	CcSEcCtD
Zoledronate—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000348	CcSEcCtD
Zoledronate—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000347	CcSEcCtD
Zoledronate—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000346	CcSEcCtD
Zoledronate—Chills—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000344	CcSEcCtD
Zoledronate—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000127	0.000344	CcSEcCtD
Zoledronate—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000343	CcSEcCtD
Zoledronate—CA2—trigeminal ganglion—peripheral nervous system neoplasm	0.000126	0.0415	CbGeAlD
Zoledronate—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000339	CcSEcCtD
Zoledronate—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000125	0.000338	CcSEcCtD
Zoledronate—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000336	CcSEcCtD
Zoledronate—Rash—Cisplatin—peripheral nervous system neoplasm	0.000124	0.000335	CcSEcCtD
Zoledronate—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000124	0.000334	CcSEcCtD
Zoledronate—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000334	CcSEcCtD
Zoledronate—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000334	CcSEcCtD
Zoledronate—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000123	0.000333	CcSEcCtD
Zoledronate—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000332	CcSEcCtD
Zoledronate—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.00033	CcSEcCtD
Zoledronate—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.00033	CcSEcCtD
Zoledronate—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000327	CcSEcCtD
Zoledronate—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000323	CcSEcCtD
Zoledronate—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000322	CcSEcCtD
Zoledronate—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000119	0.000322	CcSEcCtD
Zoledronate—CA2—parotid gland—peripheral nervous system neoplasm	0.000119	0.0391	CbGeAlD
Zoledronate—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000321	CcSEcCtD
Zoledronate—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000321	CcSEcCtD
Zoledronate—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.00032	CcSEcCtD
Zoledronate—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000319	CcSEcCtD
Zoledronate—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000317	CcSEcCtD
Zoledronate—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000117	0.000315	CcSEcCtD
Zoledronate—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000315	CcSEcCtD
Zoledronate—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000314	CcSEcCtD
Zoledronate—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000311	CcSEcCtD
Zoledronate—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000115	0.00031	CcSEcCtD
Zoledronate—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000114	0.000309	CcSEcCtD
Zoledronate—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000309	CcSEcCtD
Zoledronate—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000309	CcSEcCtD
Zoledronate—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000309	CcSEcCtD
Zoledronate—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000307	CcSEcCtD
Zoledronate—Rash—Etoposide—peripheral nervous system neoplasm	0.000113	0.000307	CcSEcCtD
Zoledronate—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000113	0.000306	CcSEcCtD
Zoledronate—Headache—Etoposide—peripheral nervous system neoplasm	0.000113	0.000305	CcSEcCtD
Zoledronate—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000303	CcSEcCtD
Zoledronate—CA2—brainstem—peripheral nervous system neoplasm	0.000111	0.0367	CbGeAlD
Zoledronate—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000301	CcSEcCtD
Zoledronate—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000111	0.0003	CcSEcCtD
Zoledronate—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000111	0.0003	CcSEcCtD
Zoledronate—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000299	CcSEcCtD
Zoledronate—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000299	CcSEcCtD
Zoledronate—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000297	CcSEcCtD
Zoledronate—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000295	CcSEcCtD
Zoledronate—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000294	CcSEcCtD
Zoledronate—Cough—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000292	CcSEcCtD
Zoledronate—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000291	CcSEcCtD
Zoledronate—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000289	CcSEcCtD
Zoledronate—Nausea—Etoposide—peripheral nervous system neoplasm	0.000107	0.000289	CcSEcCtD
Zoledronate—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000288	CcSEcCtD
Zoledronate—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000287	CcSEcCtD
Zoledronate—FDPS—cerebellum—peripheral nervous system neoplasm	0.000106	0.0348	CbGeAlD
Zoledronate—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000286	CcSEcCtD
Zoledronate—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000284	CcSEcCtD
Zoledronate—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000284	CcSEcCtD
Zoledronate—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000284	CcSEcCtD
Zoledronate—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000284	CcSEcCtD
Zoledronate—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000283	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000282	CcSEcCtD
Zoledronate—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000281	CcSEcCtD
Zoledronate—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000279	CcSEcCtD
Zoledronate—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000278	CcSEcCtD
Zoledronate—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000278	CcSEcCtD
Zoledronate—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000277	CcSEcCtD
Zoledronate—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000277	CcSEcCtD
Zoledronate—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000275	CcSEcCtD
Zoledronate—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000273	CcSEcCtD
Zoledronate—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000273	CcSEcCtD
Zoledronate—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000273	CcSEcCtD
Zoledronate—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000272	CcSEcCtD
Zoledronate—Infection—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000271	CcSEcCtD
Zoledronate—Cough—Doxorubicin—peripheral nervous system neoplasm	9.97e-05	0.00027	CcSEcCtD
Zoledronate—Shock—Epirubicin—peripheral nervous system neoplasm	9.91e-05	0.000268	CcSEcCtD
Zoledronate—Convulsion—Doxorubicin—peripheral nervous system neoplasm	9.89e-05	0.000268	CcSEcCtD
Zoledronate—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	9.88e-05	0.000267	CcSEcCtD
Zoledronate—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	9.86e-05	0.000267	CcSEcCtD
Zoledronate—Hypertension—Doxorubicin—peripheral nervous system neoplasm	9.86e-05	0.000267	CcSEcCtD
Zoledronate—Tachycardia—Epirubicin—peripheral nervous system neoplasm	9.83e-05	0.000266	CcSEcCtD
Zoledronate—Skin disorder—Epirubicin—peripheral nervous system neoplasm	9.78e-05	0.000265	CcSEcCtD
Zoledronate—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	9.74e-05	0.000264	CcSEcCtD
Zoledronate—Chest pain—Doxorubicin—peripheral nervous system neoplasm	9.72e-05	0.000263	CcSEcCtD
Zoledronate—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	9.72e-05	0.000263	CcSEcCtD
Zoledronate—Myalgia—Doxorubicin—peripheral nervous system neoplasm	9.72e-05	0.000263	CcSEcCtD
Zoledronate—Anxiety—Doxorubicin—peripheral nervous system neoplasm	9.69e-05	0.000262	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	9.66e-05	0.000261	CcSEcCtD
Zoledronate—Discomfort—Doxorubicin—peripheral nervous system neoplasm	9.61e-05	0.00026	CcSEcCtD
Zoledronate—Anorexia—Epirubicin—peripheral nervous system neoplasm	9.6e-05	0.00026	CcSEcCtD
Zoledronate—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	9.51e-05	0.000257	CcSEcCtD
Zoledronate—Hypotension—Epirubicin—peripheral nervous system neoplasm	9.41e-05	0.000255	CcSEcCtD
Zoledronate—Confusional state—Doxorubicin—peripheral nervous system neoplasm	9.4e-05	0.000254	CcSEcCtD
Zoledronate—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	9.32e-05	0.000252	CcSEcCtD
Zoledronate—Oedema—Doxorubicin—peripheral nervous system neoplasm	9.32e-05	0.000252	CcSEcCtD
Zoledronate—Infection—Doxorubicin—peripheral nervous system neoplasm	9.26e-05	0.000251	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	9.18e-05	0.000248	CcSEcCtD
Zoledronate—Shock—Doxorubicin—peripheral nervous system neoplasm	9.17e-05	0.000248	CcSEcCtD
Zoledronate—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	9.14e-05	0.000247	CcSEcCtD
Zoledronate—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	9.13e-05	0.000247	CcSEcCtD
Zoledronate—Insomnia—Epirubicin—peripheral nervous system neoplasm	9.11e-05	0.000247	CcSEcCtD
Zoledronate—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	9.1e-05	0.000246	CcSEcCtD
Zoledronate—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	9.05e-05	0.000245	CcSEcCtD
Zoledronate—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	9.05e-05	0.000245	CcSEcCtD
Zoledronate—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	9.01e-05	0.000244	CcSEcCtD
Zoledronate—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	8.98e-05	0.000243	CcSEcCtD
Zoledronate—Somnolence—Epirubicin—peripheral nervous system neoplasm	8.96e-05	0.000242	CcSEcCtD
Zoledronate—Anorexia—Doxorubicin—peripheral nervous system neoplasm	8.88e-05	0.00024	CcSEcCtD
Zoledronate—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	8.87e-05	0.00024	CcSEcCtD
Zoledronate—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	8.76e-05	0.000237	CcSEcCtD
Zoledronate—Hypotension—Doxorubicin—peripheral nervous system neoplasm	8.71e-05	0.000236	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	8.7e-05	0.000235	CcSEcCtD
Zoledronate—Fatigue—Epirubicin—peripheral nervous system neoplasm	8.68e-05	0.000235	CcSEcCtD
Zoledronate—Constipation—Epirubicin—peripheral nervous system neoplasm	8.61e-05	0.000233	CcSEcCtD
Zoledronate—Pain—Epirubicin—peripheral nervous system neoplasm	8.61e-05	0.000233	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	8.49e-05	0.00023	CcSEcCtD
Zoledronate—Insomnia—Doxorubicin—peripheral nervous system neoplasm	8.43e-05	0.000228	CcSEcCtD
Zoledronate—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	8.37e-05	0.000227	CcSEcCtD
Zoledronate—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	8.31e-05	0.000225	CcSEcCtD
Zoledronate—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	8.3e-05	0.000225	CcSEcCtD
Zoledronate—Somnolence—Doxorubicin—peripheral nervous system neoplasm	8.29e-05	0.000224	CcSEcCtD
Zoledronate—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	8.24e-05	0.000223	CcSEcCtD
Zoledronate—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	8.2e-05	0.000222	CcSEcCtD
Zoledronate—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	8.1e-05	0.000219	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	8.05e-05	0.000218	CcSEcCtD
Zoledronate—Fatigue—Doxorubicin—peripheral nervous system neoplasm	8.04e-05	0.000217	CcSEcCtD
Zoledronate—Urticaria—Epirubicin—peripheral nervous system neoplasm	8e-05	0.000217	CcSEcCtD
Zoledronate—Pain—Doxorubicin—peripheral nervous system neoplasm	7.97e-05	0.000216	CcSEcCtD
Zoledronate—Constipation—Doxorubicin—peripheral nervous system neoplasm	7.97e-05	0.000216	CcSEcCtD
Zoledronate—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	7.96e-05	0.000216	CcSEcCtD
Zoledronate—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	7.96e-05	0.000216	CcSEcCtD
Zoledronate—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	7.68e-05	0.000208	CcSEcCtD
Zoledronate—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	7.62e-05	0.000206	CcSEcCtD
Zoledronate—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	7.42e-05	0.000201	CcSEcCtD
Zoledronate—Urticaria—Doxorubicin—peripheral nervous system neoplasm	7.4e-05	0.0002	CcSEcCtD
Zoledronate—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	7.37e-05	0.000199	CcSEcCtD
Zoledronate—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	7.37e-05	0.000199	CcSEcCtD
Zoledronate—Asthenia—Epirubicin—peripheral nervous system neoplasm	7.23e-05	0.000196	CcSEcCtD
Zoledronate—Pruritus—Epirubicin—peripheral nervous system neoplasm	7.13e-05	0.000193	CcSEcCtD
Zoledronate—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	6.89e-05	0.000187	CcSEcCtD
Zoledronate—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	6.87e-05	0.000186	CcSEcCtD
Zoledronate—Asthenia—Doxorubicin—peripheral nervous system neoplasm	6.69e-05	0.000181	CcSEcCtD
Zoledronate—Dizziness—Epirubicin—peripheral nervous system neoplasm	6.66e-05	0.00018	CcSEcCtD
Zoledronate—Pruritus—Doxorubicin—peripheral nervous system neoplasm	6.59e-05	0.000178	CcSEcCtD
Zoledronate—Vomiting—Epirubicin—peripheral nervous system neoplasm	6.4e-05	0.000173	CcSEcCtD
Zoledronate—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	6.38e-05	0.000173	CcSEcCtD
Zoledronate—Rash—Epirubicin—peripheral nervous system neoplasm	6.35e-05	0.000172	CcSEcCtD
Zoledronate—Dermatitis—Epirubicin—peripheral nervous system neoplasm	6.35e-05	0.000172	CcSEcCtD
Zoledronate—Headache—Epirubicin—peripheral nervous system neoplasm	6.31e-05	0.000171	CcSEcCtD
Zoledronate—Dizziness—Doxorubicin—peripheral nervous system neoplasm	6.16e-05	0.000167	CcSEcCtD
Zoledronate—ABCC1—cerebellum—peripheral nervous system neoplasm	6.14e-05	0.0202	CbGeAlD
Zoledronate—Nausea—Epirubicin—peripheral nervous system neoplasm	5.98e-05	0.000162	CcSEcCtD
Zoledronate—Vomiting—Doxorubicin—peripheral nervous system neoplasm	5.93e-05	0.00016	CcSEcCtD
Zoledronate—Rash—Doxorubicin—peripheral nervous system neoplasm	5.88e-05	0.000159	CcSEcCtD
Zoledronate—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	5.87e-05	0.000159	CcSEcCtD
Zoledronate—Headache—Doxorubicin—peripheral nervous system neoplasm	5.84e-05	0.000158	CcSEcCtD
Zoledronate—Nausea—Doxorubicin—peripheral nervous system neoplasm	5.54e-05	0.00015	CcSEcCtD
Zoledronate—CA2—cerebellum—peripheral nervous system neoplasm	5.49e-05	0.0181	CbGeAlD
